Parental attitudes, beliefs, and perceptions about genetic testing for FAP and colorectal cancer surveillance in minors
- PMID: 20195720
- PMCID: PMC3020788
- DOI: 10.1007/s10897-010-9285-1
Parental attitudes, beliefs, and perceptions about genetic testing for FAP and colorectal cancer surveillance in minors
Abstract
Familial adenomatous polyposis (FAP) is the second most common hereditary colorectal cancer syndrome and confers a nearly 100% lifetime risk of developing colorectal cancer. Understanding factors that facilitate and inhibit genetic testing and cancer surveillance in children who are members of families affected by FAP will better equip clinicians to clarify misunderstandings and facilitate appropriate care. The aims of this study were to examine parental attitudes and beliefs regarding endoscopic surveillance and genetic testing in minors at risk for developing FAP. This cross-sectional study includes analyses of qualitative and quantitative interview data collected from parents of children with or at risk for FAP. This report includes data from 28 parents with a total of 51 biological children between 10-17 years of age. The parents had a clinical and/or genetic diagnosis of FAP. Most commonly reported facilitators included provider recommendation (surveillance) and personalized medical management (genetic testing). Most commonly reported barriers included lack of provider recommendation (surveillance) and cost (genetic testing).
References
-
- Ajzen I. The theory of planned behavior. Organizational Behavior and Human Decision Processes. 1991;50(2):179–211.
-
- Al-Sukhni W, Aronson M, Gallinger S. Hereditary colorectal cancer syndromes: familial adenomatous Polyposis and Lynch syndrome. Surgical Clinics of North America. 2008;88:819–844. - PubMed
-
- American Academy of Pediatrics Committee on Bioethics. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001;107(6):1451–1455. - PubMed
-
- American Society of Clinical Oncology. American society of clinical oncology policy statement update: genetic testing for cancer susceptibility. Journal of Clinical Oncology. 2003;21(12):2397–2406. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical